Overweight
Pharmacotechnological principles and mechanisms of action of modern injectables for weight reduction
Versandkostenfrei!
Versandfertig in 1-2 Wochen
24,90 €
inkl. MwSt.
PAYBACK Punkte
0 °P sammeln!
Slimming drugs have long since ceased to be a marginal topic in modern medicine - they are at the centre of a profound change in the way we deal with overweight and obesity. This book provides a detailed analysis of pharmacological developments from the first appetite suppressants to today's incretin mimetics such as semaglutide and tirzepatide, and focuses on the upcoming active ingredients: new combination preparations, triple agonists and individualised therapeutic approaches that are designed to specifically modulate metabolism. The focus is on the scientific principles of action, the clin...
Slimming drugs have long since ceased to be a marginal topic in modern medicine - they are at the centre of a profound change in the way we deal with overweight and obesity. This book provides a detailed analysis of pharmacological developments from the first appetite suppressants to today's incretin mimetics such as semaglutide and tirzepatide, and focuses on the upcoming active ingredients: new combination preparations, triple agonists and individualised therapeutic approaches that are designed to specifically modulate metabolism. The focus is on the scientific principles of action, the clinical evidence, and the regulatory, social and ethical issues associated with the use of these drugs. This work not only imparts current knowledge, but also shows how the medical treatment of obesity is undergoing fundamental changes - towards an evidence-based, differentiated and forward-looking form of therapy. An indispensable reference book for anyone who wants to understand why modern weight loss drugs are fundamentally changing the therapeutic self-understanding of obesity. Over the past 11 years, Bremen University Press has published over 4,500 academic books in various languages. 1st edition 2025
